Symposium: Cancer and RNA Modifications

09/06/2026 11:35 13:10

Room F9+10

SophiePostel-Vinay Co-Chair Gustave RoussyFrance

Time	Session

11:35 12:00	mRNA based therapeutics against cancer MustafaDiken Speaker BioNTech AGGermany
12:00 12:10	Proffered Paper: Pharmacological targeting of METTL1 as a novel anti-cancer strategy EACR26-1904 EACR26-1904 ElizaYankova Oral Presenter Cambridge Stem Cell Institute, University of CambridgeUnited Kingdom
12:10 12:35	A-to-I RNA Editing in Cancer ErezLevanon Speaker The Goodman Faculty of Life SciencesIsrael
12:35 12:45	Proffered Paper: Defining NXT1:NXF1-mediated RNA export as a colorectal cancer-specific vulnerability EACR26-0946 EACR26-0946 VidaKufrin Oral Presenter National Center for Tumor Diseases (NCT) DresdenGermany
12:45 13:10	Targeting RNA Methylases in Cancer Therapy: A Novel Approach to Revolutionize Treatment SandraBlanco Benavente Speaker Universidad de SalamancaSpain